Martina Borghi
Rome, 00161, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Integrative Multidimensional Profiling of Individuals Recovered from Mild COVID-19 Reveals Immune-Metabolic-Oxidative Network Interactions.
Journal: International journal of molecular sciences
Published: June 16, 2026
Sex differences in vaccine-induced immunity in mice immunized with integrase-defective lentiviral vector delivering the SARS-CoV-2 Spike protein.
Journal: Frontiers in immunology
Published: December 30, 2025
Simian Immunodeficiency Virus-Based Virus-like Particles Are an Efficient Tool to Induce Persistent Anti-SARS-CoV-2 Spike Neutralizing Antibodies and Specific T Cells in Mice.
Journal: Vaccines
Published: December 30, 2024
T Cell Peptide Prediction, Immune Response, and Host-Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects.
Journal: Biomolecules
Published: July 29, 2024
New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis.
Journal: Biomedicines
Published: January 31, 2023
Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles.
Journal: Frontiers in immunology
Published: January 19, 2023
Seasonal Betacoronavirus Antibodies' Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization.
Journal: Journal of clinical immunology
Published: September 02, 2021
Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency.
Journal: Frontiers in immunology
Published: July 30, 2021
Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers.
Journal: NPJ vaccines
Published: July 09, 2021
Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization.
Journal: Molecular therapy. Methods & clinical development
Published: April 27, 2021
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.
Journal: Nature communications
Published: January 27, 2021
Last Updated: 09/26/2026